- | | A composition for anti-cancer adjuvant comprising a RIP3 expression inducing agent or activator | 김유선 |
2016 | | Anti-cancer supplement agent comprising flunarizine for glioma | 김인영, 최경숙 |
2015 | | Anti-cancer supplement agent comprising polyether antibiotics for gliomas | 최경숙 |
2017 | | Anticancer supplement composition comprising RIP3 activator | 구기방, 김유선 |
2018 | | Anticancer supplement composition comprising RIP3 activator, Method for screening anticancer supplement agents inducing RIP3 expression for enhancing sensitivity to anticancer agents and method for monitoring sensitivity to anticancer agents | 구기방, 김유선 |
2018 | | Biomarker composition for diagnosing cancer with mitochondrial dysfunction and method for diagnosing cancer using the same marker | 우현구, 윤계순, 이영경 |
2017 | | Biomarker composition for diagnosing cancer with mitochondrial dysfunction comprising NUPR1 and method for diagnosing cancer using the same marker | 우현구, 윤계순, 이영경 |
- | | Biomarker composition for diagnosing cell senescence comprising UHRF1 and DNMT1 | 변해옥, 윤계순, 이영경 |
- | | BIOMARKER FOR PREEDICTING FEMALE SPECIFIC LIVER CANCER MALIGNANCY AND USE THEREOF | 김유선 |
- | | Biomarkers for diagnosing cancer and method for isolating cancer cell using the same | 김유선 |
2022 | | Biomarkers for diagnosing osteoarthritis | 김유선, 양시영 |
2020 | | CANCER CELL LINE FOR EVALUATING PARAPTOSIS, SCREENING METHOD FOR THE PARAPTOSIS INDUCERS AND SCREENING METHOD FOR SENSITIZERS OF PROTEASOME INHIBITORS USING THE SAME | 최경숙 |
- | | Composition and kit for cancer cell, and method for separating cancer cell using the same | 김유선 |
2018 | | Composition comprising expression regulator for preventing or treating non-alcoholic fatty liver | 유민숙, 임인경, 최정아 |
- | | Composition containing B-cell lymphoma 2 inhibitor for anti-aging and whitening | 강희영, 박태준 |
- | | Composition for preventing or treating osteoarthritis comprising Neratinib | 김유선, 양시영 |
- | | Composition for preventing or treating osteoarthritis comprising Selumetinib | 김유선, 양시영 |
2016 | | Composition for preventing or treating tumor comprising proteasome inhibitor and dihydropyridine compound | 김인영, 최경숙 |
2017 | | Composition for regulating cutaneous pigmentation derived from endothelial cells or secretory factors from endothelial cells and method for screening skin whitening agents | 강희영, 김미선, 박지윤, 박태준 |
2018 | | Composition for regulating cutaneous pigmentation or skin whitening comprising SDF1 | 강희영, 김미선, 박태준 |